Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+89.7%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+89.7%/yr
Quarterly compound
Percentile
P100
Near historical high
vs 3Y Ago
6.8x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 33.36% |
| Q3 2025 | 5.61% |
| Q2 2025 | 15.11% |
| Q1 2025 | -13.18% |
| Q4 2024 | -86.99% |
| Q3 2024 | 1.91% |
| Q2 2024 | -6.75% |
| Q1 2024 | 1.75% |
| Q4 2023 | 0.02% |
| Q3 2023 | -21.23% |
| Q2 2023 | -17.45% |
| Q1 2023 | -13.63% |
| Q4 2022 | 4.89% |
| Q3 2022 | 7.80% |
| Q2 2022 | -17.12% |
| Q1 2022 | 13.79% |
| Q4 2021 | -36.91% |
| Q3 2021 | -9.28% |
| Q2 2021 | -41.29% |
| Q1 2021 | -19.22% |
| Q4 2020 | -7.93% |
| Q3 2020 | -26.03% |
| Q2 2020 | -2.82% |
| Q1 2020 | 0.00% |